News of Note—Bavarian Nordic, FluGen and more

newspapers
(Pixabay)

Here is some other vaccine news of note for the week:

> Bavarian Nordic shipped Imvanex smallpox vaccine doses to England after authorities there recorded monkeypox cases. Release

> The National Institutes of Health is supporting phase 1 testing of a broadly protective flu vaccine developed by FluGen. Release

> Sinovac reports that the U.S. Department of Justice has closed an investigation into the company. Release

> In a preclinical study, an experimental H3N2 flu DNA vaccine from Inovio elicited antibody responses and protected against a heterologous lethal challenge. Release

Suggested Articles

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.

Former FDA Commissioner Scott Gottlieb says 40% of the population needs to be vaccinated to achieve COVID-19 herd immunity.

CanSino Bio, Moderna and a collaboration between Oxford Univeristy and AstraZeneca are frontrunners, but they all face hurdles shared and unique.